Start finding grants with Atom for

$0 today

$30 Billed monthly after 7-day trial. Cancel anytime.

Personalized grant emails delivered weekly, right to your inbox.

AI powered search engine with both keyword and semantic search capabilities.

Grant filters to find the perfect funding opportunities.

Similar Grants

Eligibility

Profile

Finance

Other

Similar Grants

Back

Neuroimaging and CSF Biomarker Program

Due: Dec 9, 2024

Alzheimer's Drug Discovery Foundation (ADDF)

$600,000

Description

The aim of this RFP is to further develop and validate established biomarkers for which there is a clear clinical need in Alzheimer's disease and related dementias. This RFP prioritizes biomarkers with a defined context of use, a clear advantage over other relevant biomarkers, and a path to commercialization and/or clinical use. Specifically, this RFP focuses on developing novel PET ligands for clinical trials, supporting novel CSF biomarkers, validating innovative MRI approaches in larger cohorts, and more. Must...

Award Amount$600,000

Eligible Applicants- Funding is open to researchers and clinicians worldwide at: Academic medical centers and universities or nonprofits. Industry partnerships are encouraged. Biotechnology companies. Existing companies and new startups are both eligible.

Funding TypeGrantCategories of Funding Activity- Science, Technology, and Research & Development- Health

Grantor Contact InformationFor scientific inquiries, please contact: Meriel Owen, PhD, Associate Director, Scientific Affairs mowen@alzdiscovery.org. For inquiries related to contracting and the online funding portal, please contact: Mission Related Investments Team grants@alzdiscovery.org

Additional informationThe ADDF focuses on advancing drug development for Alzheimer’s and related dementias and the biomarker tools that aid in this process. This RFP prioritizes biomarker programs that define a specific use and have potential for commercial and clinical translation, with an emphasis on clinical trials. The RFP supports advancement of neuroimaging and CSF biomarkers that can demonstrate target engagement for novel therapeutics, detect signs of disease earlier, more accurately diagnose and distinguish between dementia subtypes, and more.Supporting Linkhttps://www.alzdiscovery.org/research-and-grants/funding-opportunities/biomarkers

Start finding grants with Atom for

$0 today

$30 Billed monthly after 7-day trial. Cancel anytime.

Personalized grant emails delivered weekly, right to your inbox.

AI powered search engine with both keyword and semantic search capabilities.

Grant filters to find the perfect funding opportunities.

Similar Grants

Start finding grants with Atom for

$0 today

$30 Billed monthly after 7-day trial. Cancel anytime.

Personalized grant emails delivered weekly, right to your inbox.

AI powered search engine with both keyword and semantic search capabilities.

Grant filters to find the perfect funding opportunities.

Drug Development RFP

Analytical and Clinical Validation of Biomarkers for Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Optional)

Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Not Allowed)

Neuroimaging and CSF Biomarker Program

Start finding grants with Atom for

$0 today

$30 Billed monthly after 7-day trial. Cancel anytime.

Personalized grant emails delivered weekly, right to your inbox.

AI powered search engine with both keyword and semantic search capabilities.

Grant filters to find the perfect funding opportunities.

Drug Development RFP

Analytical and Clinical Validation of Biomarkers for Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Optional)

Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Not Allowed)

Neuroimaging and CSF Biomarker Program